The Moores Orthopaedic Clinic has received approval from the RCVS Ethics Review Panel to offer Biomedtrix third-generation TATE elbow replacement surgery for dogs as part of the clinical evaluation trial for this implant.
The clinic is one of just two in the UK, and the only centre in the south, to be able to offer this procedure for dogs with severe elbow osteoarthritis. The original TATE elbow replacement was in clinical use in the 2010s and the revised third-generation version is “a much-improved implant” – the clinical evaluation trial exists to monitor and document the outcomes of the redesigned implant.
Andy Moores, RCVS-recognised Specialist, clinical director and head of the joint replacement programme at The Moores Orthopaedic Clinic, says: “Canine elbow replacement can be a game-changer for dogs living with chronic elbow pain, but up until this point the elbow replacement systems have not been as reliable as we would like. The third-generation TATE implant has been in use with a small number of US surgeons for several years now and the results so far have been very promising. We are delighted that Biomedtrix have invited us to join the evaluation trial for this implant and that the RCVS Ethics Review Panel have approved this. We look forward to offering this surgery as an option for some of our most painful canine patients.”
The acceptance onto the Biomedtrix trial comes shortly after Andy became certified to perform third-generation TATE elbows earlier this year. As part of a small invite-only group, Andy attended the inaugural TATE technology course in Boston, US, to gain his certification.
Andy will offer this new procedure from his independent orthopaedic-only referral centre which opened last year.
• www.mooresortho.com or contact nfo@mooresortho.com
Comments